Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|September 21, 2010
Supplements and Featured Publications
- New and Emerging Therapies for Multiple Sclerosis and the Role of Managed Care [CME/CPE]
- Volume 16
- Issue 8 Suppl
Posttest: New and Emerging Therapies for Multiple Sclerosis and the Role of Managed Care
Advertisement
Articles in this issue
almost 16 years ago
Will the Newer Oral MS Agents Be Welcomed by Managed Care Organizations?almost 16 years ago
The Current Landscape and Unmet Needs in Multiple Sclerosisalmost 16 years ago
Participating Facultyalmost 16 years ago
Emerging Oral Agents for Multiple SclerosisAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
CMS Final Rule Ends Federal Medicaid, CHIP Funding for Youth Gender-Affirming Care
2
Trump Childhood Vaccine Order: What It Means for Parents and Payers
3
CAR T, Bispecifics Reshape Relapsed Lymphoma Care: Madhav Seshadri, MD
4
OCTOPUS Trial Aims to Speed Access to Rare Sarcoma Drugs
5